Viewpoint: Strong Mentorship 'Paramount' in Surgical Training

Share this content:
Viewpoint: Strong Mentorship 'Paramount' in Surgical Training
Viewpoint: Strong Mentorship 'Paramount' in Surgical Training

THURSDAY, Dec. 18, 2014 (HealthDay News) -- The role of mentorship is explored through the career of Alfred Blalock, M.D., in a viewpoint piece published online Dec. 17 in JAMA Surgery.

Clark D. Kensinger, M.D., from the Vanderbilt University Medical Center in Nashville, Tenn., and colleagues describe the role of mentorship throughout the career of Blalock.

The researchers note that Blalock benefited from strong mentorship under William Stewart Halsted, M.D., during his early career while in surgical training. After he did not get reappointed to the surgical program following his second year, his training continued under Samuel Crowe, M.D., chief of otolaryngology, and with Crowe's support, he acquired a general surgical residency position at Vanderbilt University. There he was mentored by Barney Brooks, M.D., who took an independent approach to mentorship, allowing Blalock to pursue his interests and offering support and recommendations for surgical societies. After advancement to chairman of surgery at Johns Hopkins, Blalock continued to accept ideas and help. In addition, he generated a successful collaborative environment by recognizing and developing talent; his personal struggles helped inspire his residents to handle adversity.

"Finding strong mentorship is paramount during surgical training," the authors write. "Mentorship is invaluable in career development because it allows for an introduction to key people, maintains productivity, and helps provide a framework for advice regarding career decisions and goals, which helps surgeons establish clinical and research priorities."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths